One in five persons in the US experience mental illness in the course of a year – and serious and persistent mental illness afflicts 5% of the population. This population has complex needs, including substance abuse and physical diseases at higher rates than the general population.

CMT is the best-in-class provider of evidence-based behavioral health analytics and decision support tools. We help payers improve prescribing, increase adherence, and better coordinate care for their costliest, most complex members, while also offering a scalable solution to address less severe behavioral health issues prevalent in their larger populations. Over the past eight years, CMT’s solutions have been used by over 30 state Medicaid agencies and numerous managed Medicaid and Medicare organizations nationwide where they have demonstrated both clinical and financial impact, including improvement in provider prescribing practice by up to 50%, reductions in ER visits and hospitalizations by up to 25%, and average behavioral pharmacy cost avoidance of $70 per intervened patient per month.